期刊文献+

人参皂苷Rg1对帕金森病小鼠黑质中酪氨酸羟化酶及ephrinB2和磷酸化c-Jun表达的影响 被引量:2

Effect of ginsenoside Rg1 on the expressions of tyrosine hydroxylase,ephrinB2 and phosphorylated c-Jun in substantia nigra of mice with Parkinson's disease
下载PDF
导出
摘要 目的观察人参皂苷Rg1对1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)所致帕金森病(PD)模型小鼠黑质中酪氨酸羟化酶(TH)mRNA、ephrinB2和磷酸化c-Jun(p-c-Jun)蛋白表达的影响,探讨人参皂苷Rg1对PD的治疗作用及其可能机制。方法将27只C57BL/6小鼠随机分为对照组、模型组和人参皂苷Rg1组,每组9只。模型组和人参皂苷Rg1组小鼠腹腔注射MPTP构建PD模型。注射MPTP前,对照组和模型组小鼠腹腔注射生理盐水(1 mL·kg-1·d-1),人参皂苷Rg1组小鼠腹腔注射人参皂苷Rg1(10 mg·kg-1·d-1),连续3 d。通过爬杆实验观察小鼠行为学变化,2周后采用反转录聚合酶链反应检测小鼠黑质中TH mRNA的表达,免疫组织化学法检测小鼠黑质中ephrinB2及p-c-Jun蛋白的表达。结果不同时间点模型组小鼠的爬杆时间均显著长于对照组和人参皂苷Rg1组,差异均有统计学意义(P<0.05);模型组小鼠脑黑质中TH mRNA表达水平显著低于对照组和人参皂苷Rg1组,差异均有统计学意义(P<0.05,P<0.01);模型组小鼠脑黑质中ephrinB2、p-c-Jun阳性表达细胞数显著高于对照组和人参皂苷Rg1组,差异均有统计学意义(P<0.05)。结论 MPTP可能通过促进小鼠中脑黑质中ephrinB2、p-c-Jun的表达及诱导多巴胺能神经元细胞凋亡导致PD;人参皂苷Rg1可能通过降低小鼠中脑黑质中ephrinB2、p-c-Jun的表达并缓解多巴胺能神经元凋亡而改善PD症状。 Objective To explore the role of ginsenoside Rgl on treatment of Parkinson's disease(PD) and its mecha- nism by observing the effect of ginsenoside Rgl on the expressions of tyrosine hydroxylase(TH) mRNA, ephrinB2 and phos- phorylated e-Jun(p-c-Jun) protein in substantia nigra of mice with PD induced by 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyri- dine (MPTP). Methods Twenty-seven C57BL/6 mice were randomly divided into control group, model group and ginsenoside Rgl group, nine mice in each group. The mice in model group and ginsenoside Rgl group were used to make models of PD by intraperitoneal injection of MPTP. Before the intraperitoneal injection of MPTP ,the mice in control group and model group were pretreated with normal saline( 1 mL·kg^-1· d^-1 ) , and the mice in ginsenoside Rgl group were pretreated with ginsenoside Rgl (10 mg · kg^-1·d^-1 ) by intraperitoneal injection for three days. The ethological changes of mice were observed by the pole test. The expression of TH mRNA in substantia nigra of the mice was determined with reverse transcription-polymerase chain reaction, and the expressions of ephrinB2 and p-c-Jun proteins in substantia nigra of the mice were detected by immuno- histochemistry after two weeks. Results The time of climbing pole of mice in model group was significantly longer than those of mice in control group and ginsenoside Rgl group at different time point( P 〈 0.05 ). The expression of TH mRNA in substantia nigra of mice in model group was significantly lower than that in control group and ginsenoside Rgl group(P 〈 0.05 ). The number of ephrinB2 and p-c-Jun positive cells in substantia nigra of mice in model group was significantly higher than that in control group and ginsenoside Rgl group ( P 〈 0.05, P 〈 0.01 ). Conclusion MPTP may promote the development of PD through inducing the expressions of ephrinB2 and p-c-Jun, and initiating dopamine neurons apoptosis. Ginsenoside Rgl may improve the symptoms of PD by decreasing the expressions of ephrinB2,p-c-Jun and restraining dopamine neurons apoptosis.
出处 《新乡医学院学报》 CAS 2014年第10期781-785,共5页 Journal of Xinxiang Medical University
基金 河南省高校科技创新人才支持计划资助项目(编号:2010HASTIT008)
关键词 帕金森病 人参皂苷RG1 酪氨酸羟化酶 EPHRINB2 磷酸化c-Jun Parkinson's disease: ainsenoside RgI tvrosine hvdroxvlase enhrinB2 phosphorylated c-Jun
  • 相关文献

参考文献3

二级参考文献77

  • 1赵晓萍,赵武伟,谢惠君,苏敬敬,郝怡鑫,韩海雄,林大宇,徐玲,汤国梅,任大明.多巴胺转运体基因可变数目串联重复多态在帕金森病易感性中的作用[J].中华老年医学杂志,2004,23(7):457-459. 被引量:1
  • 2Xiao-chunCHEN Yi-canZHOU YingCHEN Yuan-guiZHU FangFANG Li-minCHEN.Ginsenoside Rg1 reduces MPTP-induced substantia nigra neuron loss by suppressing oxidative stress[J].Acta Pharmacologica Sinica,2005,26(1):56-62. 被引量:38
  • 3Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitrite oxide and superoxide. Proc Natl Acad Sci USA 1990; 87: 1620-4.
  • 4Lin KT, Xue JY, Nomen M, Spur B, Wong PY. Peroxynitrite-induced apoptosis in HL-60 cells. J Biol Chem 1995; 270: 16487-90.
  • 5Dehmer T, Lindenau J, Haid S, Dichgans J, Schulz JB. Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in vivo.J Neurochem 2000; 74: 2213-6.
  • 6Hunot S, Boissiere E Faucheux B, Brugg B, Mouatt-Prigent A, Agid Y, et al. Nitrite oxide synthase and neuronal vulnerability in Parkinson's disease. Neuroscience 1996; 72: 355-63.
  • 7Gerlach M, Ben-Shachar D, Riederer P, Youdim MB. Altered brain metabolism of iron as a cause of neurodegenerative diseases? J Neurochem 1994; 63: 793-806.
  • 8Jenner P, Olanow CW. Pathological evidence for oxidative stress in Parkinson's disease and related degenerative disorders. In: Olanow CW, Jenner P, Youdim MBH, editors. Neurodegeneration and neuroprotection in Parkinson's disease. London: Academic Press;1996. p 24-45.
  • 9Alam ZI, Jenner A, Daniel SE, Lees A J, Cairns N, Marsden CD, et al.Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra. J Neurochem 1997; 69:1195-203.
  • 10Dexter DT, Holley AE, Flitter WD, Slater TF, Wells FR, Daniel SE, et al. Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study. Mov Disord 1994; 9: 92-7.

共引文献43

同被引文献14

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部